Evidence map›Paper›PMID 39633023›Full record

ArticleScientific reports2024

Eosinophilic inflammation that begins in the juvenile stage causes hydronephrosis and urothelial cancer in mutant mice.

Kiyokazu Ozaki, Yui Terayama, Minori Inanaga Kojima, Tetsuro Matsuura, Kiyokazu Ozaki

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kiyokazu OzakiLaboratory of Pathology, Faculty of Pharmaceutical Sciences, Setsunan University, 573-0101, Hirakata, Japan. ozaki@pharm.setsunan.ac.jp.
Yui TerayamaLaboratory of Pathology, Faculty of Pharmaceutical Sciences, Setsunan University, 573-0101, Hirakata, Japan.
Minori Inanaga KojimaLaboratory of Pathology, Faculty of Pharmaceutical Sciences, Setsunan University, 573-0101, Hirakata, Japan.
Tetsuro MatsuuraLaboratory of Pathology, Faculty of Pharmaceutical Sciences, Setsunan University, 573-0101, Hirakata, Japan.
Kiyokazu OzakiLaboratory of Pathology, Faculty of Pharmaceutical Sciences, Setsunan University, 573-0101, Hirakata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive hydronephrosis is caused by various factors such as chronic inflammation and tumors. Eosinophils and chitinase-like proteins (CLPs) are involved in the pathogenesis of hydronephrosis in mice; however, the specific mechanisms remain unknown. In this study, we morphologically analyzed a novel mouse model of obstructive hydronephrosis from onset to progression to clarify the effects of eosinophils and CLP on the development of hydronephrosis and tumorigenesis. The primary change was slight eosinophil infiltration of the ureteropelvic junction, even at 1 week of age, followed by a significant increase in CLP expression in the urothelium at 5 weeks of age, which led to proliferation of the urothelium. At 8 weeks of age, polyps with eosinophilic inflammation and urothelial hyperplasia expressing high levels of CLP formed at the ureteropelvic junction, leading to hydronephrosis. At 60 weeks of age, all mice with hydronephrosis exhibited chronic eosinophilic inflammation and adenomas that progressed to adenocarcinomas with high CLP expression. In summary, inflammation and epithelial proliferation at the ureteropelvic junction began with a single infiltration of eosinophils at the juvenile stage in mice. Eosinophilic inflammation is associated with the development of hydronephrosis and urothelial hyperplasia, which may progress to urothelial adenocarcinoma due to increased CLP expression.

Indexed as

EosinophilsHydronephrosisInflammationUrotheliumAnimalsDisease Models, AnimalHyperplasiaMiceUrologic NeoplasmsChitinase-like proteinCrystalEosinophilHydronephrosisMouseUrothelial adenocarcinoma

Identifiers

PMID39633023
PMCPMC11618632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.